Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system that delivers minimally invasive, patient-friendly therapy for personalized chronic pain relief using proprietary wirelessly powered and closed-loop sensing technologies.
2
Rounds
3
Tags
Apr 27, 2026
Latest raise
Funding activity · 2 rounds
Apr 27, 2026
$52.5M
Series B
Led by Amzak Health
Article coming soon.
Mar 4, 2025
$13M
Series A
Led by U.S. Venture Partners (USVP)
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
